Health
Results from Phase 0/1 trial of ribociclib plus everolimus in patients with high-grade glioma announced – News-Medical.Net
The Ivy Brain Tumor Center at Barrow Neurological Institute, the largest early-phase drug development program for brain cancer…
The Ivy Brain Tumor Center at Barrow Neurological Institute, the largest early-phase drug development program for brain cancer in the world, announced results from their Phase 0/1 clinical trial of ribociclib plus everolimus in patients with high-grade…
Continue Reading